BMY Jan 2026 33.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:37AM EDT. Market open.
| Previous close | 10.57 |
| Open | 10.55 |
| Bid | 8.95 |
| Ask | 11.90 |
| Strike | 33.00 |
| Expiry date | 2026-01-16 |
| Day's range | 10.55 - 10.57 |
| Contract range | N/A |
| Volume | |
| Open interest | 129 |
Business WireBristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
Simply Wall St.Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...
Business WireBristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
© 2024 Yahoo. All rights reserved.